| 9155783 |
Agents and methods based on the use of the EDA domain of fibronectin |
Claude Leclerc, Juan José Lasarte Sagastibelza, Marta Gorraiz Ayala |
2015-10-13 |
| 9049856 |
Cold organ preservation composition and method of use |
Haisul C.Y. Chang, Victor Fernández Gallego, María Iñiguez Martínez, Jose Miguel López Novoa, Juan Ruiz Echeverría |
2015-06-09 |
| 8697665 |
Porphobilinogen deaminase gene therapy |
Antonio Fontanellas Roma, Gloria GONZALEZ ASEGUINOLAZA, Maria Sol Rodriguez Pena, Maria Astrid Pañeda Rodriguez, Jaap Twisk +2 more |
2014-04-15 |
| 8524860 |
Peptides with capacity to bind to scurfin and applications |
Inés Noelia Casares Lagar, Francisco Borras Cuesta, Pablo Sarobe Ugarriza, Juan José Lasarte Sagastibelza |
2013-09-03 |
| 7829077 |
Treatment of hepatitis C with compositions comprising oncostatin M and interferon alpha |
Rafael Aldabe Arregui, Esther Larrea Leoz, María Pilar Civeira Murillo |
2010-11-09 |
| 7732397 |
Use of cardiotrophin in liver diseases |
Matilde Bustos De Abajo, Juan José Lasarte Sagastibelza, Elena BAIXERAS LLANO |
2010-06-08 |
| 7666841 |
Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) |
Javier Dotor De Las Herrerias, Ana Belen Lopez Vazquez, Juan José Lasarte Sagastibelza, Francisco Borras Cuesta |
2010-02-23 |
| 7582609 |
Method for the treatment of skin fibrosis and suitable compositions for such treatment |
Francisco Borras Cuesta, Javier Dotor De Las Herrerias, Juan Manuel Irache Garreta, Fernando Martinez Galan |
2009-09-01 |
| 7528226 |
TGFβ1-inhibitor peptides |
Ignacio José Ezquerro Saenz, Juan José Lasarte Sagastibelza, Francisco Borras Cuesta |
2009-05-05 |
| 7501392 |
Method of treatment of viral hepatitis C with interferon alpha 5 |
Ma Pilar Civeira Murillo, Esther Larrea Leoz |
2009-03-10 |
| 6995133 |
Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
Ma Pilar Civeira Murillo, Esther Larrea Leoz |
2006-02-07 |